Unique ID issued by UMIN | UMIN000043905 |
---|---|
Receipt number | R000050141 |
Scientific Title | A pilot randomized controlled trial of compassion focused therapy for depression and anxiety. |
Date of disclosure of the study information | 2021/05/06 |
Last modified on | 2021/05/18 11:07:22 |
Compassion Focused Therapy for Depression and anxiety.
Compassion Focused Therapy for Depression and anxiety.
A pilot randomized controlled trial of compassion focused therapy for depression and anxiety.
A pilot RCT of CFT for depression and anxiety.
Japan |
Major Depressive Disorder, Panic Disorder, Agoraphobia, Social Anxiety Disorder, Generalized Anxiety Disorder
Psychosomatic Internal Medicine | Psychiatry |
Others
NO
The primary endpoint of clinical efficacy will be the BDI-II at the end of the intervention (13 weeks), and the superiority of the intervention group over the control group will be examined using a randomized controlled trial.
Efficacy
Depressive symptoms as measured by the BDI-II at 13 weeks
1. severity of subjective anxiety symptoms at 13 weeks (GAD-7)
2. severity of subjective depressive symptoms at 13-week (PHQ-9)
3. quality of life at 13 weeks (EQ-5D)
4. treatment response rate at 13-week (13-week BDI-II score reduction of 50% or more compared to baseline)
5. remission rate at 13-week (BDI-II score of 13 or less at 13 weeks)
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Educational,Counseling,Training
Behavior,custom |
12 weeks of Compassion Focused Therapy (60 minutes per session)
Treatment as usual(12 weeks)
20 | years-old | <= |
65 | years-old | >= |
Male and Female
1) Patients with major depressive disorder, panic disorder, agoraphobia, social anxiety disorder, or generalized anxiety disorder in MINI
2) Have more than mild depressive symptoms (14 points or more on BDI-II)
3) Age between 20 and 65 years old at the time of screening
4) Patients with alcohol or substance dependence within last 6 months
5) Patients with manic episodes, schizophrenia and other psychotic disorders at the time of pre-intervention assessment.
6) Patients who have suicidal ideation at the time of the pre-intervention assessment.
7) Patients with severe physical illness or cognitive impairment at the time of the pre-intervention evaluation.
8) Patients who will be difficult to visit the hospital more than 50%.
9) Patients receiving other structured psychotherapy at the time of the pre-intervention evaluation.
24
1st name | Masaya |
Middle name | |
Last name | Ito |
National Center of Neurology and Psychiatry
National Center for Cognitive Behavior Therapy and Research
187-8551
Ogawahigashi4-1-1, Kodaira-shi, Tokyo, Japan
042-341-2711
masayait@ncnp.go.jp
1st name | Kenichi |
Middle name | |
Last name | Asano |
National Center for Cognitive Behavior Therapy and Research
National Center for Cognitive Behavior Therapy and Research
187-8551
Ogawahigashi4-1-1, Kodaira-shi, Tokyo, Japan
042-341-2711
kenichi-asano@ncnp.go.jp
National Center for Cognitive Behavior Therapy and Research, National Center of Neurology and Psychiatry
Japan Society for the Promotion of Science
Japanese Governmental office
Institutional Review Board, National Center of Neurology and Psychiatry
awahigashicho 4-1-1, Kodaira-shi, Tokyo, Japan
042-341-2711
ml_rinrijimu@ncnp.go.jp
NO
2021 | Year | 05 | Month | 06 | Day |
Unpublished
Enrolling by invitation
2021 | Year | 04 | Month | 12 | Day |
2021 | Year | 05 | Month | 07 | Day |
2021 | Year | 05 | Month | 21 | Day |
2024 | Year | 03 | Month | 31 | Day |
2021 | Year | 04 | Month | 13 | Day |
2021 | Year | 05 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050141